The Evaluation and Treatment (Tx) of Burkitt Lymphoma (BL) in the Modern Era: Real World (RW) Outcomes and Prognostication across 26 US Cancer Centers (CC)

Andrew M. Evens1, Alexey Danilov2, Deepa Jagadeesh3, et al.

1 Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA
2 Knight Cancer Institute, Division of Hematology & Medical Oncology, Oregon Health & Science University, Portland, OR, USA
3 Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA